Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation

Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebo Sponsors:   Kristin Hudock;   Kiniksa Pharmaceuticals, Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials